相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Ankita Mehta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice
David Tweedie et al.
EXPERIMENTAL NEUROLOGY (2013)
Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury
David Tweedie et al.
NEUROBIOLOGY OF DISEASE (2013)
Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
Isidro Salcedo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The Effect of Injury Severity on Behavior: A Phenotypic Study of Cognitive and Emotional Deficits after Mild, Moderate, and Severe Controlled Cortical Impact Injury in Mice
Patricia M. Washington et al.
JOURNAL OF NEUROTRAUMA (2012)
Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis
Yazhou Li et al.
PLOS ONE (2012)
Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection
Hai Chen et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
Niklas Marklund et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neuroprotective properties of GLP-1: theoretical and practical applications
Jens Juul Holst et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus Current and Emerging Agents
Baptist Gallwitz
DRUGS (2011)
Targeting amyloid-beta by glucagon-like peptide-1 (GLP-1) in Alzheimer's disease and diabetes
Ann Mosegaard Bak et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model
Paola Luciani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Diffuse Brain Injury Elevates Tonic Glutamate Levels and Potassium-Evoked Glutamate Release in Discrete Brain Regions at Two Days Post-Injury: An Enzyme-Based Microelectrode Array Study
Jason M. Hinzman et al.
JOURNAL OF NEUROTRAUMA (2010)
Effects of Traumatic Brain Injury of Different Severities on Emotional, Cognitive, and Oxidative Stress-Related Parameters in Mice
Marcelo L. Schwarzbold et al.
JOURNAL OF NEUROTRAUMA (2010)
Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus
Hua Li et al.
NEUROSCIENCE LETTERS (2010)
Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
Bronwen Martin et al.
DIABETES (2009)
Long-term Psychiatric Outcomes Following Traumatic Brain Injury: A Review of the Literature
Dale C. Hesdorffer et al.
JOURNAL OF HEAD TRAUMA REHABILITATION (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury
Anna M. B. Heile et al.
NEUROSCIENCE LETTERS (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
Modulation of the cAMP signaling pathway after traumatic brain injury
Coleen M. Atkins et al.
EXPERIMENTAL NEUROLOGY (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Apoptotic and behavioral sequelae of mild brain trauma in mice
David Tweedie et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Incidence of traumatic brain injury in the United States, 2003
Wesley Rutland-Brown et al.
JOURNAL OF HEAD TRAUMA REHABILITATION (2006)
A systematic review of brain injury epidemiology in Europe
F Tagliaferri et al.
ACTA NEUROCHIRURGICA (2006)
Impaired spatial learning in a novel rat model of mild cerebral concussion injury
N Henninger et al.
EXPERIMENTAL NEUROLOGY (2005)
A systematic review of treatments for mild traumatic brain injury
P Comper et al.
BRAIN INJURY (2005)
Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons
CP Gilman et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The glucagon-like peptides: a double-edged therapeutic sword?
T Perry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Entry of exendin-4 into brain is rapid but may be limited at high doses
AJ Kastin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice
O Zohar et al.
NEUROSCIENCE (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Traumatic brain injury in the elderly: Increased mortality and worse functional outcome at discharge despite lower injury severity
M Susman et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2002)
Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans
PM Lenzlinger et al.
JOURNAL OF NEUROTRAUMA (2001)
Apoptosis after traumatic brain injury
R Raghupathi et al.
JOURNAL OF NEUROTRAUMA (2000)
分享论文
